SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000880771-16-000193
Filing Date
2016-09-29
Accepted
2016-09-29 20:20:17
Documents
1
Period of Report
2016-09-29

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT certent-form4.html 4  
1 PRIMARY DOCUMENT certent-form4.xml 4 9877
  Complete submission text file 0000880771-16-000193.txt   11256
Mailing Address 950 TOWER LANE SUITE 900 FOSTER CITY CA 94404-2125
Business Address 950 TOWER LANE SUITE 900 FOSTER CITY CA 94404-2125 650-358-3456
SCICLONE PHARMACEUTICALS INC (Issuer) CIK: 0000880771 (see all company filings)

IRS No.: 943116852 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 101 WESTCOTT SUITE 603 HOUSTON TX 77007
Business Address
CHANG NANCY T (Reporting) CIK: 0001135041 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-19825 | Film No.: 161911112